Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)
Condition(s):Hematological Abnormality; HematotoxicityLast Updated:April 13, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Hematological Abnormality; HematotoxicityLast Updated:April 13, 2023Completed
Condition(s):Hematological Abnormalities in covid19Last Updated:January 10, 2022Unknown status
Condition(s):Angiodysplasia; Hematological DiseaseLast Updated:December 21, 2023Not yet recruiting
Condition(s):Hematological MalignancyLast Updated:December 26, 2018Unknown status
Condition(s):Hematologic DiseasesLast Updated:March 31, 2023Not yet recruiting
Condition(s):CXCR4; PET/CT; Hematological MalignancyLast Updated:December 1, 2022Recruiting
Condition(s):Hematopoietic Stem Cell Transplantation; Malignant Hematological DiseasesLast Updated:July 6, 2023Recruiting
Condition(s):Hematological Diseases; Carbapenem-resistant Enterobacteriaceae; Carbapenem-resistant Pseudomonas Aeruginosa; Carbapenem-resistant Acinetobacter BaumanniiLast Updated:August 12, 2021Unknown status
Condition(s):Hematological MalignanciesLast Updated:June 8, 2015Unknown status
Condition(s):COVID-19 Infection in Hematological Malignancies PatientsLast Updated:November 22, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.